# OptimizeRx Corp (OPRX)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/optimizerx-corp/ JSON: https://steadybase.io/company/optimizerx-corp.json Checked Nov 10, 2026. Latest filing read: Aug 20, 2026.

## Company

- Legal name: OptimizeRx Corp
- Ticker: OPRX (Nasdaq)
- SEC CIK: 0001448431
- Industry: Services-Business Services, NEC (SIC 7389)
- Headquarters: Waltham, MA
- Fiscal year ends: December 31
- SEC filer category: Non-accelerated filer<br>Smaller reporting company
- Website: optimizerx.com
- LinkedIn: https://www.linkedin.com/company/oprx
- Next earnings date: Nov 11, 2026

## Key facts

- Revenue: $109.4M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 12, 2026). Source: https://www.sec.gov/Archives/edgar/data/1448431/000144843126000005/0001448431-26-000005-index.html
- Operating income: $11.7M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 12, 2026). Source: https://www.sec.gov/Archives/edgar/data/1448431/000144843126000005/0001448431-26-000005-index.html
- Net income: $5.1M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 12, 2026). Source: https://www.sec.gov/Archives/edgar/data/1448431/000144843126000005/0001448431-26-000005-index.html
- SG&A: $33.5M for the fiscal year ended Dec 31, 2022 (10-K filed Mar 10, 2023). Source: https://www.sec.gov/Archives/edgar/data/1448431/000121390023019233/0001213900-23-019233-index.html
- Employees: 104 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1448431/000144843126000005/oprx-20251231.htm
- Shares outstanding: 18,835,951 as of Jul 30, 2026 (10-Q filed Aug 13, 2026). Source: https://www.sec.gov/Archives/edgar/data/1448431/000144843126000016/0001448431-26-000016-index.html
- Auditor: Uhy LLP, Sterling Heights, Michigan, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1448431/000144843126000005/oprx-20251231.htm

## Business

OptimizeRx is a leading digital healthcare technology company that is redefining how life sciences brands engage with, market their services and products to, and support patients and healthcare providers. We leverage our proprietary technology solutions and partnerships to help our clients develop and execute highly individualized and targeted marketing campaigns to drive physician and patient engagement and to enhance patient care.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1448431/000144843126000005/oprx-20251231.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $109.4M | $11.7M | $5.1M | n/a |
| Dec 31, 2024 | $92.1M | -$13.7M | -$20.1M | n/a |
| Dec 31, 2023 | $71.5M | -$26.4M | -$17.6M | n/a |
| Dec 31, 2022 | $62.5M | -$12.3M | -$11.4M | $33.5M |
| Dec 31, 2021 | $61.3M | $361,100 | $378,079 | $27.7M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/optimizerx-corp.json

## Officers and directors

- Stephen L. Silvestro, Chief Executive Officer. LinkedIn: https://linkedin.com/in/stephensilvestro. Source: Form 4 filed Aug 24, 2026, https://www.sec.gov/Archives/edgar/data/1448431/000162828026058673/0001628280-26-058673-index.htm
- Andrew D'Silva, Chief Financial Officer. Source: 8-K filed Aug 12, 2026, https://www.sec.gov/Archives/edgar/data/1448431/000144843126000014/oprx-20260807.htm
- Brendan W. Merrell, CHIEF OPERATING OFFICER. Source: Form 4 filed Aug 24, 2026, https://www.sec.gov/Archives/edgar/data/1448431/000162828026058670/0001628280-26-058670-index.htm
- Brendan Merrell, Chief Operating Officer. LinkedIn: https://www.linkedin.com/in/brendanmerrell. Source: 10-K filed Mar 12, 2026, https://www.sec.gov/Archives/edgar/data/1448431/000144843126000005/oprx-20251231.htm
- Andrew J. D'Silva, Chief Business Officer. Source: Form 4 filed Sep 2, 2026, https://www.sec.gov/Archives/edgar/data/1448431/000162828026060059/0001628280-26-060059-index.htm
- Edward Stelmakh, Chief Finance & Strat Officer. LinkedIn: https://www.linkedin.com/in/edstelmakh. Source: Form 4 filed Aug 24, 2026, https://www.sec.gov/Archives/edgar/data/1448431/000162828026058583/0001628280-26-058583-index.htm
- Marion Odence-Ford, Chief Legal & Admin Officer. LinkedIn: https://linkedin.com/in/marion-odence-ford-117b. Source: Form 4 filed Aug 24, 2026, https://www.sec.gov/Archives/edgar/data/1448431/000162828026058669/0001628280-26-058669-index.htm
- Heather Favazza, Chief Accounting Officer. LinkedIn: https://www.linkedin.com/in/heather-favazza. Source: 8-K filed Aug 12, 2026, https://www.sec.gov/Archives/edgar/data/1448431/000144843126000014/oprx-20260807.htm
- Theresa Greco, Chief Commercial Officer. LinkedIn: https://www.linkedin.com/in/theresagreco. Source: Form 4 filed May 18, 2026, https://www.sec.gov/Archives/edgar/data/1448431/000162828026036004/0001628280-26-036004-index.htm
- Doug Besch, Chief Product & Technology Officer. LinkedIn: https://www.linkedin.com/in/douglasbesch. Source: 10-K filed Mar 12, 2026, https://www.sec.gov/Archives/edgar/data/1448431/000144843126000005/oprx-20251231.htm
- Gregory Wasson, Board member (per proxy). Source: DEF 14A filed Apr 30, 2026, https://www.sec.gov/Archives/edgar/data/1448431/000121390026049698/ea0287361-03.htm
- Lynn O'Connor Vos, Board member (per proxy). Source: DEF 14A filed Apr 30, 2026, https://www.sec.gov/Archives/edgar/data/1448431/000121390026049698/ea0287361-03.htm
- Patrick Spangler, Board member (per proxy). Source: DEF 14A filed Apr 30, 2026, https://www.sec.gov/Archives/edgar/data/1448431/000121390026049698/ea0287361-03.htm
- Stephen Silvestro, Named in proxy. Source: DEF 14A filed Apr 30, 2026, https://www.sec.gov/Archives/edgar/data/1448431/000121390026049698/ea0287361-03.htm

## Recent 8-K events

- Aug 12, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 5.02, Departure or appointment of directors or officers; compensation; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1448431/000144843126000014/oprx-20260807.htm
- Jun 12, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 5.07, Submission of matters to a vote of security holders; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1448431/000121390026068272/ea0294565-8k_optimize.htm
- Jun 5, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/1448431/000121390026065810/ea0293598-8k_optimize.htm
- May 12, 2026: Item 1.01, Entry into a material definitive agreement; Item 1.02, Termination of a material definitive agreement; Item 2.02, Results of operations and financial condition (earnings release); Item 2.03, Creation of a direct financial obligation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1448431/000144843126000009/oprx-20260512.htm
- Apr 9, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1448431/000121390026041604/ea0285473-8k_optimize.htm
- Mar 30, 2026: Item 4.01, Changes in registrant's certifying accountant; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1448431/000144843126000007/oprx-20260324.htm
- Mar 5, 2026: Item 1.01, Entry into a material definitive agreement; Item 2.02, Results of operations and financial condition (earnings release); Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1448431/000144843126000002/oprx-20260305.htm
- Nov 6, 2025: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1448431/000144843125000018/oprx-20251106.htm
- Aug 19, 2025: Item 5.02, Departure or appointment of directors or officers; compensation; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1448431/000121390025078162/ea0253741-8k_optimize.htm
- Aug 7, 2025: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1448431/000144843125000010/oprx-20250807.htm

## Insider trades (Form 4)

- Dec 19, 2025: Edward Stelmakh (Chief Finance & Strat Officer) sold 1,388 shares, about $18,752. Source: https://www.sec.gov/Archives/edgar/data/1448431/000162828025058413/0001628280-25-058413-index.htm
- Oct 3, 2025: Stephen L. Silvestro (Chief Executive Officer) sold 1,620 shares, about $30,375. Source: https://www.sec.gov/Archives/edgar/data/1448431/000162828025044543/0001628280-25-044543-index.htm
- Aug 28, 2025: Patrick D. Spangler (Director) sold 11,120 shares, about $194,489. Source: https://www.sec.gov/Archives/edgar/data/1448431/000129652525000002/0001296525-25-000002-index.htm

## Latest filings

- 8-K filed Aug 12, 2026: https://www.sec.gov/Archives/edgar/data/1448431/000144843126000014/oprx-20260807.htm
- 10-K filed Mar 12, 2026: https://www.sec.gov/Archives/edgar/data/1448431/000144843126000005/oprx-20251231.htm
- 10-Q filed Aug 13, 2026: https://www.sec.gov/Archives/edgar/data/1448431/000144843126000016/oprx-20260630.htm
- DEF 14A filed Apr 30, 2026: https://www.sec.gov/Archives/edgar/data/1448431/000121390026049698/ea0287361-03.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/